Abacavir Sulfate; Lamivudine; Zidovudine Patent Expiration

Abacavir Sulfate; Lamivudine; Zidovudine is Used for treating patients infected with HIV. It was first introduced by Viiv Healthcare Co in its drug Trizivir on Nov 14, 2000. 2 different companies have introduced drugs containing Abacavir Sulfate; Lamivudine; Zidovudine.


Abacavir Sulfate; Lamivudine; Zidovudine Patents

Given below is the list of patents protecting Abacavir Sulfate; Lamivudine; Zidovudine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trizivir US5905082 Crystalline oxathiolane derivatives May 18, 2016

(Expired)

Viiv Hlthcare
Trizivir US5905082

(Pediatric)

Crystalline oxathiolane derivatives Nov 18, 2016

(Expired)

Viiv Hlthcare
Trizivir US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections May 14, 2018

(Expired)

Viiv Hlthcare
Trizivir US6294540

(Pediatric)

Carbocyclic nucleoside hemisulfate and its use in treating viral infections Nov 14, 2018

(Expired)

Viiv Hlthcare
Trizivir US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC Mar 28, 2016

(Expired)

Viiv Hlthcare
Trizivir US6417191

(Pediatric)

Synergistic combinations of zidovudine, 1592U89 and 3TC Sep 28, 2016

(Expired)

Viiv Hlthcare


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Abacavir Sulfate; Lamivudine; Zidovudine Generics

Only one generic application has been filed for Abacavir Sulfate; Lamivudine; Zidovudine.

Given below is the list of companies who have filed for Abacavir Sulfate; Lamivudine; Zidovudine generic.


1. LUPIN LTD

Lupin Ltd has filed for 1 generic for Abacavir Sulfate; Lamivudine; Zidovudine. This eq 300mg base;150mg;300mg version comes by the name ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE; 150MG; 300MG

(reference standard)

tablet Prescription ORAL N/A Dec 5, 2013